EcoR1 Capital
Mr. Lee joined EcoR1 Capital as an Analyst in April 2020. He is responsible for due diligence and analysis of biotechnology companies for value-oriented investment opportunities. Prior to joining EcoR1, Mr. Lee spent two years at Goldman Sachs in San Francisco, where he performed strategic and financial analyses related to M&A transactions and equity offerings for clients in the biotechnology sector. He graduated from Harvard University with a Bachelor of Arts in Neurobiology.
This person is not in any teams
This person is not in any offices
EcoR1 Capital
EcoR1 Capital is a biotech-focused investment advisory firm established in 2013, which invests in companies at all stages of research and development.